GTR 120195082
Tenders Are Invited For Various Medicinal Products – Biosimilars: Infliximab Iv, Tocilizumab Iv And Sc, Denosumab Sc And Epoëtine Alfa
ICB — International Competitive Bid
Closes Dec 01, 2026
Western Europe
Tender Information
GTR Reference
120195082
Tendering Authority
Subscribe to view
Tender No
763149-2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Various Medicinal Products – Biosimilars: Infliximab Iv, Tocilizumab Iv And Sc, Denosumab Sc And Epoëtine Alfa
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Western Europe
Political Region
European Union
Last Date of Bid Submission
01-12-2026
Work Detail
Various Medicinal Products – Biosimilars: Infliximab Iv, Tocilizumab Iv And Sc, Denosumab Sc And Epoëtine Alfa. Infliximab Iv,Tocilizumab,Denosumab Sc,Epoëtine Alfa
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
2314491c-7eee-4f6a-92d7-cd1381f77a76.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.